AbCellera Biologics Company
AbCellera Biologics is a biotechnology company that develops antibody therapeutics to improve patient outcomes.
Investors
Connections from
Headquarters:
Vancouver, British Columbia, Canada
Industry:
Early Drug Development
Employee Number:
101-250
Estimated Revenue:
$10M to $50M
Investors Number:
12.0
Funding Status:
IPO
Last Funding Type:
Series B
Founded Date:
2012-01-01
Total Funding:
371217878.0
Last Funding Date:
2020-05-27